SINOVAC BIOTECH LTD
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $15.8M | $9.00B | $11.61B |
| FY2022 | $11.8M | $8.49B | $3.88B |
| FY2023 | $253.9M | $8.32B | $1.12B |
| FY2024 | $375.8M | $8.26B | $335.3M |
| FY2025 | $494.9M | $4.44B | $488.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $15.8M | $9.00B | $11.61B |
| FY2022 | $11.8M | $8.49B | $3.88B |
| FY2023 | $253.9M | $8.32B | $1.12B |
| FY2024 | $375.8M | $8.26B | $335.3M |
| FY2025 | $494.9M | $4.44B | $488.2M |